Colorectal Cancer

Our medical, surgical, and radiation oncologists, gastroenterologists, and radiologists provide comprehensive, coordinated treatment and seamless care for people with even the most complex colorectal cancers, all under one roof. We personalize your treatment plan based on the location of the tumor, how advanced it is, and its molecular and genetic features.

Our clinical trials provide new and promising treatment options for people with early and more advanced colorectal cancer. NYU Langone doctors also offer high-quality colon cancer screening at convenient locations throughout the New York City area.

Clinical Trials and Research Studies

Phase 1

Phase 1b Open-label Study of MK-7162 in Combination with Pembrolizumab (MK-3475) +/- other therapies in Participants with Advanced Solid Tumors

Learn More

Phase 1/2

A PHASE 1B/2 OPEN-LABEL STUDY TO EVALUATE SAFETY CLINICAL ACTIVITY PHARMACOKINETICS AND PHARMACODYNAMICS OF AVELUMAB (MSB0010718C) IN COMBINATION WITH OTHER CANCER IMMUNOTHERAPIES IN PATIENTS WITH ADVANCED MALIGNANCIES

Learn More

Phase 3

A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon or Rectal Cancer Phase III Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)

Learn More

Phase 1/2

A Phase 1b/2 Open-label Dose Escalation Study of Entinostat in Combination With Pembrolizumab in Patients With Non-small Cell Lung Cancer With Expansion Cohorts in Patients With Non-small Cell Lung Cancer and Melanoma

Learn More